About Immune Control
Immune Control is a company based in Conshohocken (United States) founded in 2001.. Immune Control has raised $11.3 million across 2 funding rounds from investors including Broadmark Realty Capital, BioAdvance and NewSpring Capital. Immune Control operates in a competitive market with competitors including AmerisourceBergen, Renee, Apothkary, AvKARE and Cencora, among others.
- Headquarter Conshohocken, United States
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$11.3 M (USD)
in 2 rounds
-
Latest Funding Round
$11.3 M (USD), Series A
Jul 13, 2005
-
Investors
Broadmark Realty Capital
& 4 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Immune Control
Immune Control has successfully raised a total of $11.3M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $11.3 million completed in July 2005. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Series A — $11.3M
- First Round First Round
- Investors Count 5
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2005 | Amount | Series A - Immune Control | Valuation |
investors |
|
| Mar, 2005 | Amount | Debt – Conventional - Immune Control | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Immune Control
Immune Control has secured backing from 5 investors, including venture fund and institutional investors. Prominent investors backing the company include Broadmark Realty Capital, BioAdvance and NewSpring Capital. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Founded Year | Domain | Location | |
|
Investment firm focusing on lower-middle market growth, healthcare, and various strategies.
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Immune Control
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Immune Control
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Immune Control Comparisons
Competitors of Immune Control
Immune Control operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as AmerisourceBergen, Renee, Apothkary, AvKARE and Cencora, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Pharmaceutical distribution and supply chain services are provided globally.
|
|
| domain | founded_year | HQ Location |
Diversified drugs are distributed by Renee in the United States.
|
|
| domain | founded_year | HQ Location |
Provides herbal formulas for stress relief, energy, mood, and wellness support.
|
|
| domain | founded_year | HQ Location |
Pharmaceuticals and infection control products are distributed by AvKARE.
|
|
| domain | founded_year | HQ Location |
Clinical trial logistics and biopharma outsourcing services are provided globally.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Immune Control
When was Immune Control founded?
Immune Control was founded in 2001 and raised its 1st funding round 4 years after it was founded.
Where is Immune Control located?
Immune Control is headquartered in Conshohocken, United States. It is registered at Conshohocken, Pennsylvania, United States.
Is Immune Control a funded company?
Immune Control is a funded company, having raised a total of $11.3M across 2 funding rounds to date.
What does Immune Control do?
Immune Control, established in 2001, excels in providing healthcare solutions, pharmaceutical distributors, and diversified. Limited information available. Committed to advancing standards, it focuses on innovation, efficiency, and delivering value to clients worldwide. It continues to evolve, meeting industry challenges with strategic approaches.
Who are the top competitors of Immune Control?
Immune Control's top competitors include AmerisourceBergen, AvKARE and Cencora.
Who are Immune Control's investors?
Immune Control has 5 investors. Key investors include Broadmark Realty Capital, BioAdvance, NewSpring Capital, Anthem Capital, and Domain Associates.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.